期刊文献+

高迁移率族蛋白B1和基质金属蛋白酶-2、9在喉癌组织中的表达及其与预后的关系 被引量:20

Expressions of HMGB1,MMP-2 and MMP-9 and prognostic alue in human laryngeal carcinoma
原文传递
导出
摘要 目的:探讨喉癌组织中高迁移率族蛋白B1(HMGB1)和基质金属蛋白酶(MMP)-2、MMP-9的表达及其与临床病理特征和预后的关系。方法:应用免疫组织化学EnVision二步法检测61例喉癌组织中HMGB1和MMP-2、MMP-9蛋白表达;实时荧光定量PCR法检测30例喉癌组织中HMGB1和MMP-2、MMP-9mRNA表达。结果:HMGB1和MMP-2、MMP-9蛋白在喉癌组织中的阳性表达率明显高于癌旁正常组织(χ2值分别为44.934和49.923、36.054,均P<0.01);HMGB1和MMP-2、MMP-9mRNA在喉癌组织中的相对表达水平明显高于癌旁正常组织(t值分别为5.940和7.005、7.664,均P<0.01);HMGB1和MMP-2、MMP-9蛋白表达均与喉癌T分期、临床分期和淋巴结转移有关(P<0.05或<0.01);HMGB1和MMP-9蛋白在喉癌组织中的表达呈正相关(r=0.381,P<0.01),HMGB1和MMP-2蛋白在喉癌组织中的表达无相关性(r=0.094,P>0.05);Kap-lan-Meier生存分析结果显示,HMGB1和MMP-9表达阳性患者的生存率低于表达阴性患者(χ2值分别为4.974、6.418,均P<0.05);COX回归分析显示,HMGB1是危险因子,其表达越高,患者预后越差(P<0.05)。结论:HMGB1和MMP-2、MMP-9与喉癌的浸润、转移有关;HMGB1和MMP-9的表达有协同促进作用;HMGB1可能是影响预后的独立危险因素。 Objective:To investigate the expressions of high mobility group box B1 protein(HMGB1),matrix metalloproteinases-2(MMP-2) and matrix metalloproteinases-9(MMP-9) in human laryngeal carcinoma and study their relationships with clinicopathological characteristics and prognosis.Method:The expressions of HMGB1,MMP-2 and MMP-9 proteins were examined with the EnVision immunohistochemical method in 61 cases of laryngeal carcinoma.The expressions of HMGB1,MMP-2 and MMP-9 mRNA were detected by real-time quantitative RT-PCR method in 30 cases of laryngeal carcinoma.Result:The positive expression rates of HMGB1,MMP-2 and MMP-9 proteins were significantly higher in laryngeal carcinoma than those in adjacent tissue(χ2=44.934,49.923 and 36.054,P0.01).The relative expression levels of HMGB1,MMP-2 and MMP-9 mRNA in laryngeal carcinoma were significantly higher than those in adjacent tissue(t=5.940,7.005 and 7.664,P0.01).The high level expression of HMGB1,MMP-2,MMP-9 proteins was closely associated with T stage,clinical stage and the status of lymph node metastasis(P0.05 or P0.01).There was a positive correlation between the expression of HMGB1 and MMP-9 protein(r=0.381,P0.01).Univatiate analysis indicated that the overall survival rate was lower in patients with a positive expression of HMGB1 and MMP-9 than those with negative expression(χ2=4.974,6.418,P0.05).Multivariate analysis showed that HMGB1 was a risk predictor.A higher expression of HMGB1 was associated with a shorter survival time.Conclusion:HMGB1,MMP-2 and MMP-9 play a role in invasion and metastasis of laryngeal carcinoma;Also there is a synergistic effect between HMGB1 and MMP-9;Moreover HMGB1 may be a independent prognostic factor.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2013年第4期181-187,共7页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 南京市科技局社会发展项目基金资助(No:200702075) 南京市卫生局基金资助(No:YKK07071)
关键词 喉肿瘤 高迁移率族蛋白类 基质金属蛋白酶类 预后 laryngeal neoplasms high mobility group box 1 protein matrix metalloproteinases prognosis
  • 相关文献

参考文献12

  • 1Xingjun Yao,Gang Zhao,Hongfa Yang,Xinyu Hong,Li Bie,Guojin Liu.Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma[J].Journal of Cancer Research and Clinical Oncology.2010(5)
  • 2Nora Kostova,Stanislava Zlateva,Iva Ugrinova,Evdokia Pasheva.The expression of HMGB1 protein and its receptor RAGE in human malignant tumors[J].Molecular and Cellular Biochemistry (-).2010(1-2)
  • 3Christopoulos TA,Papageorgakopoulou N,Ravazoula P,etal.Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma[].Oncology Reports.2007
  • 4Saussez S,Cludts S,Capouillez A, et al.Identification of matrixmetalloproteinase-9as an independent prognostic marker in laryngeal andhypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1and-7[].International Journal of Oncology.2009
  • 5Ra HJ,Parks WC.Control of matrix metallo-proteinase catalytic activity[].Matrix Biology.2007
  • 6H Ohmori,Y Luo,H Kuniyasu.Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer[].Expert Opinion on Therapeutic Patents.2011
  • 7Liu Y,Xie C,Zhang X,etal.Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance[].European Journal of Cancer.2010
  • 8LIU P L,TSAI J R,HWANG J J,et al.High-mobility groupbox 1-mediated matrix metalloproteinase-9 expressionin non-small cell lung cancer contributes to tumor cellinvasiveness[].Am J Respir Cell Mol Biol.2010
  • 9Taguchi A,Blood DC,del Toro G,et al.Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases[].Nature.2000
  • 10Ishiguro H,Nakaigawa N,Miyoshi Y,et al.Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development[].Prostate The.2005

同被引文献176

  • 1许燕飞,冯青杰,滕博,赵婕,马丽.喉鳞状细胞癌组织中Galectin-3表达与Bcl-2、Mmp-2及K-ras表达的相关性分析[J].吉林大学学报(医学版),2011,37(6):1116-1119. 被引量:2
  • 2张凡,常永霞,张九鸿,舒丽莎,陈江平,刘军超,林媛媛,张剑虹,赵秀芳,成日青.早期宫颈癌局部浸润与临床预后关系的研究[J].河北北方学院学报(医学版),2007,24(1):1-5. 被引量:2
  • 3李平栋,于振坤,黄志刚,房居高,倪鑫,王琪,范尔钟,杜延顺,赵丽萍,李颖.喉癌MMP-2和TIMP-2表达与瘤内微血管密度的相关性[J].中国耳鼻咽喉头颈外科,2007,14(9):514-518. 被引量:4
  • 4RA H J,PARKS W C. Control of matrix metallopro- teinase catalytic activity[J]. Matrix Biol, 2007, 26: 587-596.
  • 5TURPEENNIEMI-HUJANEN T. Gelatinases (MMP-2 and-9) and their natural inhibitors as prognostic indica- tors in solid cancers[J]. Biochimie, 2005, 87:287- 297.
  • 6GONZALEZ-ARRIAGA P, PASCUAL T, GARCIA- ALVAREZ A,et al. Genetic polymorphisms in MMP 2, 9 and 3 genes modi{y lung cancer risk and survival [J]. BMC Cancer,2012,12:121-121.
  • 7DOS REIS S T, PONTES J Jr. , VILLANOVA F E, et al. Genetic polymorphisms of matrix metalloprotei- nases: susceptibility and prognostic implications for prostate cancer[J]. J Urol,2009,181 : 2320- 2325.
  • 8SFAR S, SAAD H, MOSBAH F, et al. TSP1 and MMP9 genetic variants in sporadic prostate cancer [J]. Cancer Genet Cytogenet, 2007,172 : 38- 44.
  • 9VAIRAKTARIS E, VASSILIOU S, NKENKE E, et al. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma [J]. Eur J Surg Oncol, 2008, 34:450-455.
  • 10NASR H B, MESTIRI S, CHAHED K,et al. Matrix metalloproteinase-1 (-1607) 1G/2G and-9 (-1562) C/T promoter polymorphisms: susceptibility and prog- nostic implications in nasopharyngeal carcinomas[J]. Clin Chim Acta, 2007, 384 : 57- 63.

引证文献20

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部